New York City, NY -- (SBWIRE) -- 01/02/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts.
Grab your cell phone and text the word "PICKS" to "555888”. StockMarketIntel.com issues a special report on the following stocks: Barrick Gold Corporation (USA) (NYSE:ABX), CME Group Inc (NASDAQ:CME), Cell Therapeutics Inc (NASDAQ:CTIC), Twenty-First Century Fox Inc (NASDAQ:FOXA)
Barrick Gold Corporation (USA) (NYSE:ABX) gained 3.01% recently, while trading on 3.36 million shares, at the price of $18.15. The stock changed hands in a range of $17.91 to $18.32 up till now, bringing its market capitalization at about $21.19 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $13.43 and was moved to the maximum level of $36.08. Barrick Gold Corporation (Barrick) is engaged in the production and sale of gold, as well as related activities, such as exploration and mine development. Barrick also produces copper, principally from the Zaldivar and Lumwana mines and holds other interests, including a nickel development project located in Africa.
For How Long ABX will fight for Profitability? Read This Trend Analysis report
CME Group Inc (NASDAQ:CME) declined -0.87% recently, in the current trading session, at $77.78 with a total volume of 712,883 shares. The stock, on average, trades on a volume of 1.89 million shares. It floated in a range of $77.61 to $78.75 during the recent trading session, with a beta value of 1.11. Its market capitalization now moved to about $26.08 billion. In the past 52 weeks, the share price has not declined below $51.00 or above $84.71. CME Group Inc. (CME Group) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. The Company’s products include both exchange-traded and over-the-counter derivatives.
Has CME Found The Bottom and Ready To Move Up? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) recently recorded a gain of 6.66% and was moving within a range of $2.01-$2.13, its current trading price is $2.04. The stock is moving up till now with a total volume of 2.74 million shares, versus an average volume of 2.18 million shares. The share price hit its 52-week low of $0.97 and $2.17 was the best price. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
For How Long CTIC Gloss will Attract Investors? Find out via this report
Twenty-First Century Fox Inc (NASDAQ:FOXA) added 0.97% in its current trading activity, bringing its market capitalization around $81.00 billion. The share price, after opening at $35.47, hit a high of $35.52 and hovered above $35.27, while its recent trading price was $35.54. The total number of shares changed hands during the current session up till now was 2.40 million shares, as compared to average trading volume of 9.05 million shares. Twenty-First Century Fox, Inc., formerly News Corporation, has a portfolio of cable, broadcast, film, pay television and satellite assets spanning six continents across the globe. The Company is home to a global portfolio of cable and broadcasting networks and properties, including FOX, FX, FXX, FS1, Fox News Channel, Fox Business Network, Fox Sports, Fox Sports Network, National Geographic Channels, Fox Pan American Sports, MundoFox, STAR and 28 local television stations; film studio Twentieth Century Fox Film; and television production studios Twentieth Century Fox Television and Shine Group.
Will FOXA Continue To Move Higher? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts.
Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)